Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, First-in-Human Study of PRL3-ZUMAB In Advanced, Solid Tumors and Haematologic Malignancies

NCT03191682 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT03191682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03191682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, First-in-Human Study of PRL3-ZUMAB In Advanced, Solid Tumors and Haematologic Malignancies
Lead sponsor
National University Hospital, Singapore
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 20, 2017
Completion date
February 20, 2027
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors